Pathkey.AI secures commercial contract with Imunexus
Pathkey.AI (ASX:PKY) has executed a strategic services agreement with Imunexus Therapeutics.
Pathkey.AI (ASX:PKY) has executed a strategic services agreement with Imunexus Therapeutics.
NASA's crew of astronauts launched to space and reached a stable orbit, kicking off a landmark journey that will take them closer to the lunar surface than anyone has been in more than 50 years.
X2M Connect (ASX:X2M) has formalised a smart community agreement with Resi Ventures.
Trump is scheduled to deliver a rare primetime address on Wednesday night as the Strait of Hormuz remains largely closed, with markets in turmoil and economic growth threatened worldwide.
Actinogen Medical (ASX:ACW) announced the commencement of the open-label extension phase for its pivotal XanaMIA trial.
Synlait Milk (ASX:SM1) has completed the sale of its North Island assets to global healthcare giant Abbott.
Ore Resources (ASX:OR3) has consolidated its exploration footprint within the Eastern Goldfields of Western Australia.
NASA astronauts lifted off on a 10-day journey that will slingshot them around the moon, marking humanity's return to the lunar vicinity for the first time in more than half a century.
Duratec (ASX:DUR) announced an expansion of its footprint through the acquisition of Davhold Australia, operating as Pacific Welding Australia.
Northern Star Resources (ASX:NST) has reaffirmed its commitment to meet revised production targets following a complex third-quarter update.
The Indian rupee faces renewed pressure amid weak capital flows, high fuel prices and global uncertainty. Neeraj Gambhir, Executive Director at Axis Bank, spoke with Haslinda Amin on Insight with Haslinda Amin about whether USD-INR could slide to 100 and how the RBI may respond.
The Australian Securities and Investments Commission has released the final findings of its unprecedented nine-month enquiry into the ASX (ASX:ASX).